Teppei Takeshima

Yokohama City University Medical Center

Papers

2

Total Citations

11

H-Index

2

About

Teppei Takeshima is a leading urological surgeon whose research centers on male sexual dysfunction and reproductive health following minimally invasive cancer surgery. His landmark contribution is the prospective, multicenter LANDMARC study, which systematically investigated the incidence of erectile and ejaculatory dysfunction after laparoscopic, robotic, and transanal approaches for rectal cancer. This work, already cited 8 times since its 2024 publication, provides critical evidence for surgeons and patients weighing quality-of-life outcomes after modern cancer treatment. Takeshima has also advanced microsurgical technique with his work on the AccuVein AV500 device, demonstrating its utility in differentiating veins from arteries during microsurgical varicocelectomy—a common procedure for male infertility. By applying innovative imaging technology to refine surgical precision, he addresses the significant impact of varicoceles, which affect 40% of infertile men. Takeshima’s research bridges the gap between oncologic outcomes and patient-centered functional recovery, making him a key voice in the evolving field of sexual medicine and reproductive urology.

Research Focus

Key Achievements

2
H-Index
2
Papers
11
Total Citations
6
Avg Citations/Paper
🏆 Most Cited Paper
Prospective Multicenter Comprehensive Survey on Male Sexual Dysfunction following Laparoscopic, Robotic, and Transanal Approaches for Rectal Cancer (the LANDMARC Study)
8 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 32
🏛 Institutions: Yokohama City University Medical Center

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago